Status:
COMPLETED
Patient Reported Outcomes in Chronic Myeloid Leukemia
Lead Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions:
Chronic Myeloid Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
Although the impact of disease and treatment related burden on health-related quality of life (HRQOL) in patients with solid tumours has been well studied, with several clinical trials that included H...
Detailed Description
The development process will follow the international guidelines published by the EORTC Quality of Life Group (QLG). This process will follow three main phases. Phase 1 of will deal with the review o...
Eligibility Criteria
Inclusion
- Adult patients (18 years of age or older)
- Confirmed diagnosis of Philadelphia chromosome positive CML
- Informed consent provided
- Patients enrolled in investigational treatment trials are eligible
- Ability to speak and read language of the Questionnaire
Exclusion
- Freedom from overt cognitive impairment or major psychiatric conditions that may confound HRQOL evaluation
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT01252589
Start Date
November 1 2010
End Date
September 1 2013
Last Update
September 14 2016
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana-Farber Cancer Institute Harvard University
Boston, Massachusetts, United States
2
Innsbruck University Hospital
Innsbruck, Austria
3
University of Ghent
Ghent, Belgium
4
Centre Hospitalier Universitaire of Poitiers
Poitiers, France